When healthcare advances, so must the processes to connect patients to the therapies they need. And because a rapidly changing cell and gene therapy industry requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection.
Let’s build the future together.
Distribution and Commercialization Services
Market Access and Reimbursement
Innovative delivery systems, like cell and gene therapies, are requiring new levels of coordination and orchestration of multiple services, from scheduling and complex logistics to provider preparation and patient services, in order to ensure treatment success. We have an incredible opportunity to meet the growing challenges of our industry and be the “go-to” global partner for manufactures in need of specialty solutions from clinical through commercial life stages.
Working together with manufacturers to identify and overcome barriers
Expert guidance on market access, reimbursement and policy
Complete logistics support, from pre-clinical through clinical trials to commercialization and post-launch solutions to ensure product quality standards are maintained
Established relationships with thousands of healthcare providers optimizes the order to cash process and ease of prodcut access
Innovative patient access, affordability and adherence solutions unique to cell and gene therapies
Complete data solutions provide visibility to the patient journey
Advanced Therapies Treatment Centres
Redefining moments that matter
We approach every touchpoint along the cell and gene therapy commercialization and treatment timeline with the patient in mind. When we all collaborate to deliver potentially life-saving solutions, we can start redefining the moments that matter for patients, clinicians and our key stakeholders.
Connect with our experts
Glenn Martin, VP, Branded & Specialty Rx Channel Strategy & Strategic Accounts
Melissa Lattanzi, Sr Director, Specialty & Branded Channel Strategy and Product Access
AmerisourceBergen in the News
Xcenda's Ana Stojanovska Shares Insights on Market Access and Reimbursement for Cell and Gene Therapies with pharmaphorum
August, 4, 2020
In The Realm of Cell and Gene Therapies World Courier Delivers
January 15, 2020
Unifying Cell Therapy Logistics and Manufacturing
December 5, 2019